Advanced search
Publication Cover
Infection and Drug Resistance Volume 16, 2023 - Issue
Submit an article Journal homepage
83
Views
0
CrossRef citations to date
0
Altmetric
SHORT REPORT

Resistance Transition of Pseudomonas aeruginosa in SARS-CoV-2-Uninfected Hospitalized Patients in the Pandemic

Jin Xia1 Department of Respiratory and Critical Care Medicine, Affiliated Hospital/Clinical College of Chengdu University, Chengdu, Sichuan, 610081, People’s Republic of ChinaView further author information
,
Lan Lu2 Antibiotics Research and Re-Evaluation Key Laboratory of Sichuan Province, Chengdu University, Chengdu, Sichuan, 610106, People’s Republic of ChinaView further author information
,
Ke-Lei Zhao2 Antibiotics Research and Re-Evaluation Key Laboratory of Sichuan Province, Chengdu University, Chengdu, Sichuan, 610106, People’s Republic of ChinaCorrespondence[email protected]
View further author information
&
Qiang-Lin Zeng1 Department of Respiratory and Critical Care Medicine, Affiliated Hospital/Clinical College of Chengdu University, Chengdu, Sichuan, 610081, People’s Republic of ChinaCorrespondence[email protected]
View further author information
Pages 6717-6724 | Received 28 May 2023, Accepted 31 Aug 2023, Published online: 16 Oct 2023

References

  • Meskini M, Rezghi Rami M, Maroofi P, Ghosh S, Siadat SD, Sheikhpour M. An overview on the epidemiology and Immunology of COVID-19. J Infect Public Health. 2021;14(10):1284–1298. doi:10.1016/j.jiph.2021.07.021
  • Pollard CA, Morran MP, Nestor-Kalinoski AL. The COVID-19 pandemic: a global health crisis. Physiol Genomics. 2020;52(11):549–557. doi:10.1152/physiolgenomics.00089.2020
  • Lai CC, Chen SY, Ko WC, Hsueh PR. Increased antimicrobial resistance during the COVID-19 pandemic. Int J Antimicrob Agents. 2021;57(4):106324. doi:10.1016/j.ijantimicag.2021.106324
  • Li CH, Huang X, Cai M, Chen P. Expert consensus on personal protection in different regional posts of medical institutions during COVID-19 epidemic period. Chin J Infect Control. 2020;19(3):198–213.
  • Qin S, Xiao W, Zhou C, et al. Pseudomonas aeruginosa: pathogenesis, virulence factors, antibiotic resistance, interaction with host, technology advances and emerging therapeutics. Signal Transduct Target Ther. 2022;7(1):199. doi:10.1038/s41392-022-01056-1
  • Wang Z, Yu M, Lin L. The emerging antimicrobial resistance crisis during the COVID-19 surge in China. Lancet Microbe. 2023;4(5):e290–e291. doi:10.1016/S2666-5247(23)00038-1
  • Mesquita GP, Costa MCC, Silva MA, et al. Antimicrobial resistance of Pseudomonas aeruginosa isolated from patients with pneumonia during the COVID-19 pandemic and pre-pandemic periods in Northeast Brazil. Braz J Med Biol Res. 2023;56:e12726. doi:10.1590/1414-431x2023e12726
  • Chinese govt stresses regular epidemic control; 2020. Available from: http://english.www.gov.cn/premier/news/202004/30/content_WS5eaad5e8c6d0b3f0e9496ca2.html. Accessed June 16, 2022.
  • Bai YL, Liu YX, Feng D, Gao Y. Practical management of outpatient, emergency department and hospitalized patients in large scale general hospital during COVID-19 epidemic. Chin J Nosocomiol. 2020;30(8):1135–1140.
  • Rodloff A, Bauer T, Ewig S, Kujath P, Muller E. Susceptible, intermediate, and resistant - The intensity of antibiotic action. Dtsch Arztebl Int. 2008;105(39):657–662. doi:10.3238/arztebl.2008.0657
  • Subedi D, Vijay AK, Willcox M. Overview of mechanisms of antibiotic resistance in Pseudomonas aeruginosa: an ocular perspective. Clin Exp Optom. 2018;101(2):162–171. doi:10.1111/cxo.12621
  • Qu J, Cai Z, Liu Y, et al. Persistent bacterial coinfection of a COVID-19 patient caused by a genetically adapted pseudomonas aeruginosa chronic colonizer. Front Cell Infect Microbiol. 2021;11:641920. doi:10.3389/fcimb.2021.641920
  • Hu FP, Guo Y, Zhu DS, Wang F, Jiang XF, Xu YC. CHINET surveillance of bacterial resistance: results of 2020. Chin J Infect Chemother. 2021;21(4):377–387.
  • Kariyawasam RM, Julien DA, Jelinski DC, et al. Antimicrobial resistance (AMR) in COVID-19 patients: a systematic review and meta-analysis (November 2019-June 2021). Antimicrob Resist Infect Control. 2022;11(1):45. doi:10.1186/s13756-022-01085-z
  • Gysin M, Acevedo CT, Haldimann K, et al. Antimicrobial susceptibility patterns of respiratory Gram-negative bacterial isolates from COVID-19 patients in Switzerland. Ann Clin Microbiol Antimicrob. 2021;20(1):64. doi:10.1186/s12941-021-00468-1
  • van de Pol AC, Boeijen JA, Venekamp RP, et al. Impact of the COVID-19 pandemic on antibiotic prescribing for common infections in the Netherlands: a primary care-based observational cohort study. Antibiotics. 2021;10(2):196. doi:10.3390/antibiotics10020196
  • Getahun H, Smith I, Trivedi K, Paulin S, Balkhy HH. Tackling antimicrobial resistance in the COVID-19 pandemic. Bull World Health Organ. 2020;98(7):442. doi:10.2471/BLT.20.268573
  • Botelho J, Grosso F, Peixe L. Antibiotic resistance in Pseudomonas aeruginosa - Mechanisms, epidemiology and evolution. Drug Resist Updat. 2019;44:100640. doi:10.1016/j.drup.2019.07.002
  • Tacconelli E, Carrara E, Savoldi A, et al. Discovery, research, and development of new antibiotics: the WHO priority list of antibiotic-resistant bacteria and tuberculosis. Lancet Infect Dis. 2018;18(3):318–327. doi:10.1016/S1473-3099(17)30753-3
  • Rawson TM, Ming D, Ahmad R, Moore LSP, Holmes AH. Antimicrobial use, drug-resistant infections and COVID-19. Nature Reviews Microbiology. 2020;18(8):409–410. doi:10.1038/s41579-020-0395-y

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.